The investigation conducted in response to the claim that medicine manufacturers and tender pharmaceutical warehouses violated the Act no 4054 on the Protection of Competition by colluding and by means of practices for price fixing and overpricing in selling medicine to hospitals was concluded.  

As a result of the discussion of the contents of the file on 01.07.2021, the Competition Board decided that

Among the investigated undertakings,

• Undertakings titled Gül Ecza Deposu Sanayi ve Ticaret A.Ş. and Sonuç Ecza Deposu A.Ş. conducted practices violating article 4 of the Act no 4054; thus they shall be imposed administrative fines,
• Undertakings titled Deva Holding A.Ş. and Haver Farma İlaç A.Ş. did not violate article 4 of the Act no 4054 under the current circumstances; thus it is not necessary to impose fines to the said undertakings.

Click here for the text of the pronouncement of the decision dated 01.07.2021 and numbered 21-33/446-222, the reason for which will be notified later and which can be appealed before Ankara Administrative Courts.